Notice of Partial Revision of Stock Compensation Plan
Start of COPD Patient Education Joint Program with the City of Takamatsu and AstraZeneca K.K.
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2024
JAST Starts Provision of Medical Data Sets on the JDEX Data Marketplace
Notice of Revision to Sales and Earnings Forecast
Announcement of Receipt of Salesforce Japan Partners Award 2024
Notice of Dividends from Surplus
Notice of Partial Revision to the Articles of Incorporation
Results of Joint Research with Osaka Metropolitan University Using the REZULT Medical Big Data Platform Healthcare Expenditure Reduction Due to a New Railway Station
Recommendation Service for City of Kobe Using Disease Risk Forecasting AI